Assessing the effect of concomitant administration of artemether-lumefantrine and ciprofloxacin on some cardiac parameters in Wistar rats: “The remedial role of vitamin E”
DOI:
https://doi.org/10.30574/gscbps.2021.17.1.0276Keywords:
Malaria, Artemether-lumefantrine, Ciprofloxacin, Vitamin E, Cardiac FunctionAbstract
The effect of Vitamin E on some cardiac parameters following concomitant administration of artemether-lumefantrine (AL) and ciprofloxacin in male Wistar rats was investigated. Thirty-five male Wistar rats weighing between 190 – 220 g, used for the study were randomly divided into seven groups of five animals each. Group I served as the control. Group II - VII were administered; 8 mg/kg body weight (bw) of AL; 7.14 mg/kg bw of Ciprofloxacin; 8 mg/kg bw of AL + 7.14 mg/kg bw of Ciprofloxacin; 8 mg/kg bw of AL + 8.57 IU of Vitamin E; 7.14 mg/kg bw of Ciprofloxacin + 8.57 IU of Vitamin E; and 8 mg/kg bw of AL + 7.14 mg/kg bw of Ciprofloxacin + 8.57 IU of Vitamin E respectively. All the drugs were administered at their therapeutic regimen. Some cardiac parameters investigated include lipid profile, Troponin I, Troponin T, Creatine kinase, Lactate dehydrogenase and aspartate aminotransferase. The result showed significant (p < 0.05) increase in all the parameters of cardiac function when treatment groups were compared with control. The observed increase in cardiac indices were however significantly (p < 0.05) ameliorated in Groups V, VII and VII which were co-administered with Vitamin E compared with Groups II, III and IV which received the test drugs independently. The weights of the heart tissues showed the same trend with the parameters of cardiac function assessed and upon administration of vitamin E. The results obtained suggest the antioxidative role of vitamin E in alleviating the negative effects induced by artemether-lumefantrine and ciprofloxacin combination treatment, which may be from the impact of free radicals that may have been generated by the combined drugs.
Metrics
References
WHO (World Health Organization) Economic cost of malaria. Roll back malaria program report. 2008.
Eneanya CI. Seasonal variation in malaria episodes among residents of Udi, a semi-urban community in Southeast Nigeria. Nigerian Journal of Parasitology. 1998; 19(1): 39 – 43.
Caraballo H. Emergency department management of mosquito-borne illness: Malaria, dengue and West Nile virus. Emergency Medicine Practice. 2014; 16: 5 - 11.
Federal Ministry of Health (FMH). Federal Ministry of Health. A road map for malaria control in Nigeria, a bridged version, Abuja. Strategic Plan, 2009-2013, Yahian Press Ltd. 2010; 155.
WHO (World Health Organization). Guidelines for the treatment of malaria. Geneva: WHO. 2015.
Little RJ, Pestano AA, Parra Z. Modeling of peroxide activation in Artemisinin derivatives by serial docking. Journal of Molecular and Modeling. 2009; 15: 847 – 857.
Ukwenya VO, Tijani AS, Sodunke GA, Fakunle JB. Acute administration of co-artesiane induces oxidative stress in the testes of adult male Wistar rats. Bioscience Research and Communication. 2010; 22(5): 259 – 265.
Kalra SP, Naithani N, Mehta SR, Swamy AJ. Current trends in the management of typhoid fever. Armed Forces Indian Medical Journal. 2003; 59: 130 – 135.
Olcay E, Neytemur O, Kaleagasioglu F. Oral toxicity of Pefloxacin, Norfloxacin, Ofolaxcin and Ciprofloxacin. Comparison of biochemical and histopathological effects of achilles tendon in rats. Journal of Toxicological Science. 2011; 36(3): 339 – 345.
Alhassan HM, Shidali NN, Managa SB, Abdullahi K, Hamid KM. Co-infection profile of Salmonella typhi and malaria parasite in Sokoto- Nigeria. Global Journal of Science, Engineering and Technology. 2012; 2(201): 13 - 20.
Uwah AF, Ndem JI, Akpan EJ. Combining Artesunate-Amodiaquine and Ciprofloxacin improves serum lipid profile of mice exposed to Plasmodium berghei. International Journal of Biomedical Research. 2014; 5(8): 487 – 489.
Sharma B, Matlani M, Gaind R, Pandey K. Malaria and Typhoid co-infection in India: A Diagnostic Difficulty. Journal of Dental and Medical Science. 2016; 15(9): 101 – 104.
Croft AM, Whitehouse DP, Cook GC, Beer MD. Safety evaluation of the drugs available to prevent malaria. National Library of medicine. 2002; 1(1): 19 – 27.
Baxter K. (Ed). Stockley’s Drug Interactions. London: Pharmaceutical press. 2010.
Ojewole JAO. Drug Interactions In: Therapeutic Basis of Clinical Pharmacy In The Tropics, Third edition. Enugu: SNAAP press. 2004; 21 - 42.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemotherapy. 1972; 18: 499 – 502.
Nkereuwen E, Paul OO, Elias A. Effect of Artemether treatment on plasma lipid profile in malaria. Pharmacology and Pharmacy. 2014; 5: 646 – 656.
Rao SP, Miller S, Rosenbaum R, Lakier JB. Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations. American Journal of Cardiology. 1999; 43: 467 – 475.
Schimmel KJ, Richel DJ, Van den Brink RB, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treatment Review. 2004; 30(2): 181 – 191.
Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, Gustafsson S, Kanoni S, Gann AA, Chen J. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature Genetics. 2013; 45: 1345 – 1352.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes C. AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Journal of American College of Cardiology. 2014; 64(24): 2654 - 2687.
Shekelle PGM, Morton SC, Jungvig LK, Udani J, Spar M, Tu WJ, Coulter I, Newberry SJ, Hardy M. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. International Journal of General Medicine. 2004; 19(4): 380 – 389.
Marz W, Kleber ME, Scharnagl H. HDL-cholesterol: reappraisal of its clinical relevance. Clinical Research and Cardiology. 2017; 106(9): 663-75.
Nicholis SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoehagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE. Statins, high-density lipoprotein cholesterol and regression of coronary atherosclerosis. The Journal of American Medical Association. 2007; 297: 499 – 508.
Etim OE, Akpan EJ, Akpanabiatu MI. Effect of co-administration of chloroquine and cefuroxime axetil on serum lipids and lipid peroxidation in albino Wistar rats. International Journal of Biochemistry, Bioinformatics and Biotechnology studies. 2018; 3(1): 15 – 20.
Nna VU, Ofemi OE, Archibong AN, Bassey SC. Alteration in serum lipid profile following separate administration of antimalarial drugs (coartem and chloroquine): A comparative study. Der Pharma Chemica, 2014; 6(4): 415 – 421.
Thomsen M, Varbo A, Tybjaerg-Hansen A, Nordestgaard, BG. Low non-fasting triglycerides and reduced all-cause mortality: A mendelian randomization study. Clinical Chemistry. 2014; 60: 737 – 746.
Johansen CT, Hegele RA. Using Mendelian randomization to determine causative factors in cardiovascular disease. Journal of International Medicine. 2013; 273: 44 – 47.
Ukpanukpong RU, Eteng MU, Dasofunjo K. Antioxidant interactions of pefloxacin, garlic, vitamins C and E on lipid profile level of albino Wistar rats. Journal of Applied Pharmaceutical Science. 2013; 3(3): 167 – 170.
Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiology Reviews. 2004; 84: 1381 – 1478.
Vasudevan DM, Sreekumari S, Kannnan V. Textbook of Biochemistry for Medical Students, Seven edition. 2013; 301 – 310.
WHO (World Health Organization). The cardiotoxicity of Antimalarials: Report of the WHO evidence review group. Geneva. Switzerland. 2016.
Wallace KB, Starkov AA. Mitochondrial targets of drug toxicity. Annual Reviews in Pharmacology and Toxicology. 2000; 40: 353 – 388.
Wallace KB. Mitochondrial target of drug therapy. Trends in Pharmacological Sciences Journal. 2008; 29: 361-366.
Sardao VA, Pereira SL, Oliveira PJ. Drug induced mitochondrial dysfunction in cardiac and skeletal muscle injury. Expert Opinion on Drug Safety. 2008; 7(2): 129 - 146.
Brewster LM, Coronel CM, Sluiter W, Clark JF, van Montfrans GA, Saks, V. (ed.). Ethnic differences in tissue creatine kinase activity: An observational study. PLOS one. 2012; 7(3): 32471.
Young DS. Effects of drugs on clinical laboratory tests, third edition. Washington DC: AACC press. 1990; 120 – 122.
Sathasivam S, Lecky B. Statin induced myopathy. Biomedical Journal. 2008; 337(3): 22 - 86.
Lee A. Adverse drug reactions. Second edition, Great Britain Pharmaceutical Press. 2009.
Bannwarth B. Drug-induced myopathies. Expert Opinion on Drug Safety. 2002; 1(1): 65 – 70.
Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: A review. Journal of Applied Pharmacological Science. 2012; 2(5): 233 – 243.
Al-faris OJ, Al-Shawi NN, Kako MD. Possible cardiac adverse effects induced by therapeutic doses of Ciprofloxacin in Juvenile rats. Iraqi Journal of Pharmaceutical Science. 2012; 21: 2.
Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and screening, diagnosis and monitoring. Clinical Chemistry. 2000; 46(12): 2027 – 2049.
Minuk WS, Vaher D, Vogelstein B. The Metabolic and Molecular Bases of Inherited Diseases. 8th Edition. New York. 2005; 5313 – 5329.
Hirsh A, Lundquist IB. Therapeutic effects of Ciprofloxacin on the pharmacokinetics of Carbamezepine in healthy adult. Journal of Pharmaceutics. 2009; 24(1): 63 – 68.
Akpanyung EO, Bassey UE, Usoh IF, Iba IU. Effect of Combined Administration of Artequin® and Pefloxacin on some Indices of Liver and Renal Functions of Male Albino Wistar Rats. Pharmacologyonline. 2015; 3: 84 – 90.
Ugokwe CU, Awobode HO. Alterations in water quality, enzyme levels and haematology of oreochromisniloticus (Nile tilapia) from River Ogun at Abeokuta Nigeria. International Research Journal of Environmental Sciences. 2015; 4(10): 1 – 9.
Iniaghe OM, Malomo SO, Adebayo JO. Hepatoprotective effect of the aqueous extract of leaves of Acalypha racemosa in carbon tetrachloride treated rats. International Research Journal of Plant Science. 2008; 2: 301 – 305.
Nwachukwu NF, Mishra M, Marcelle T, Owolabi JB. Effects of vitamins in Augmentation of malaria treatment: A review. Asian Pacific Journal of Health Sciences. 2016; 3(4): 34 – 43.
Lazic SE, Semenova E, Williams DP. Determining organ weight toxicity with Bayesian causal models: Improving on the analysis of relative organ weights. Scientific Report. 2020; 10: 6625.
Otuechere CA, Edewor G, Kale OE, Ekor M. Subacute Therapeutic Dosing of Artemether-Lumefantrine and Artesunate-Amodiaquine Combination Preserves Plasma Cholesterol, Renal Antioxidant Status, and Organ Weights in Rats. Malaria Research and Treatment. 2012; 1 – 5.
Obaleye JA, Akinremi CA, Balogun EA, Adebayo JO. Toxicological Studies and Antimicrobial Properties of some Iron (III) Complexes of Ciprofloxacin. African Journal of Biotechnology. 2007; 6(24): 2826 – 2832.
Ajibade AJ, Fakunle PB, Adewusi MO, Oyewo OO. Some Morphological Findings on the Heart of Adult Wistar Rats Following Experimental Artesunate Administration. Current Research in Cardiovascular Pharmacology. 2012; 1(1): 1 – 9.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.